242 related articles for article (PubMed ID: 29713145)
21. Antagonizing circRNA_002581-miR-122-CPEB1 axis alleviates NASH through restoring PTEN-AMPK-mTOR pathway regulated autophagy.
Jin X; Gao J; Zheng R; Yu M; Ren Y; Yan T; Huang Y; Li Y
Cell Death Dis; 2020 Feb; 11(2):123. PubMed ID: 32054840
[TBL] [Abstract][Full Text] [Related]
22. Changes of Ghrelin/GOAT axis and mTOR pathway in the hypothalamus after sleeve gastrectomy in obese type-2 diabetes rats.
Wang Q; Tang W; Rao WS; Song X; Shan CX; Zhang W
World J Gastroenterol; 2017 Sep; 23(34):6231-6241. PubMed ID: 28974889
[TBL] [Abstract][Full Text] [Related]
23. Oleuropein Induces AMPK-Dependent Autophagy in NAFLD Mice, Regardless of the Gender.
Porcu C; Sideri S; Martini M; Cocomazzi A; Galli A; Tarantino G; Balsano C
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30544824
[TBL] [Abstract][Full Text] [Related]
24. Sweroside alleviates hepatic steatosis in part by activating AMPK/mTOR-mediated autophagy in mice.
Ding Y; Chen Y; Hu K; Yang Q; Li Y; Huang M
J Cell Biochem; 2023 Jul; 124(7):1012-1022. PubMed ID: 37269482
[TBL] [Abstract][Full Text] [Related]
25. Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway.
Zhu X; Bian H; Wang L; Sun X; Xu X; Yan H; Xia M; Chang X; Lu Y; Li Y; Xia P; Li X; Gao X
Free Radic Biol Med; 2019 Sep; 141():192-204. PubMed ID: 31226399
[TBL] [Abstract][Full Text] [Related]
26. Ginsenoside Rg
Shi Y; Chen J; Qu D; Sun Q; Yu Y; Zhang H; Liu Z; Sha J; Sun Y
Nutrients; 2024 Mar; 16(6):. PubMed ID: 38542753
[TBL] [Abstract][Full Text] [Related]
27. Eugenol ameliorates hepatic steatosis and fibrosis by down-regulating SREBP1 gene expression via AMPK-mTOR-p70S6K signaling pathway.
Jo HK; Kim GW; Jeong KJ; Kim DY; Chung SH
Biol Pharm Bull; 2014; 37(8):1341-51. PubMed ID: 25087956
[TBL] [Abstract][Full Text] [Related]
28. The SGLT2 inhibitor empagliflozin negatively regulates IL-17/IL-23 axis-mediated inflammatory responses in T2DM with NAFLD via the AMPK/mTOR/autophagy pathway.
Meng Z; Liu X; Li T; Fang T; Cheng Y; Han L; Sun B; Chen L
Int Immunopharmacol; 2021 May; 94():107492. PubMed ID: 33647823
[TBL] [Abstract][Full Text] [Related]
29. Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease
Li CX; Gao JG; Wan XY; Chen Y; Xu CF; Feng ZM; Zeng H; Lin YM; Ma H; Xu P; Yu CH; Li YM
World J Gastroenterol; 2019 Sep; 25(34):5120-5133. PubMed ID: 31558861
[TBL] [Abstract][Full Text] [Related]
30. P2Y2R Deficiency Ameliorates Hepatic Steatosis by Reducing Lipogenesis and Enhancing Fatty Acid β-Oxidation through AMPK and PGC-1α Induction in High-Fat Diet-Fed Mice.
Dusabimana T; Park EJ; Je J; Jeong K; Yun SP; Kim HJ; Kim H; Park SW
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073834
[TBL] [Abstract][Full Text] [Related]
31. Lp-PLA2 silencing ameliorates inflammation and autophagy in nonalcoholic steatohepatitis through inhibiting the JAK2/STAT3 pathway.
Yao J; Zhao Y
PeerJ; 2023; 11():e15639. PubMed ID: 37397012
[TBL] [Abstract][Full Text] [Related]
32. BabaoDan attenuates high-fat diet-induced non-alcoholic fatty liver disease via activation of AMPK signaling.
Sheng D; Zhao S; Gao L; Zheng H; Liu W; Hou J; Jin Y; Ye F; Zhao Q; Li R; Zhao N; Zhang L; Han Z; Wei L
Cell Biosci; 2019; 9():77. PubMed ID: 31548878
[TBL] [Abstract][Full Text] [Related]
33. Crocin ameliorates hepatic steatosis through activation of AMPK signaling in db/db mice.
Luo L; Fang K; Dan X; Gu M
Lipids Health Dis; 2019 Jan; 18(1):11. PubMed ID: 30621686
[TBL] [Abstract][Full Text] [Related]
34. Vanadium(IV)-chlorodipicolinate alleviates hepatic lipid accumulation by inducing autophagy via the LKB1/AMPK signaling pathway in vitro and in vivo.
Huang Y; Liu F; Zhang F; Liu P; Xu T; Ding W
J Inorg Biochem; 2018 Jun; 183():66-76. PubMed ID: 29558683
[TBL] [Abstract][Full Text] [Related]
35. The effect of ghrelin O-acyltransferase inhibitor on gastric H
Du GM; Luo BP; Hu ZH; Wu JG; Yan WM; Han ZQ; Zhang YH; Liu MJ
Gen Comp Endocrinol; 2018 Oct; 267():167-171. PubMed ID: 29966658
[TBL] [Abstract][Full Text] [Related]
36. Total flavonoids of Broussonetia papyrifera alleviate non-alcohol fatty liver disease via regulating Nrf2/AMPK/mTOR signaling pathways.
Wang Q; Wei Y; Wang Y; Yu Z; Qin H; Zhao L; Cheng J; Shen B; Jin M; Feng H
Biochim Biophys Acta Mol Cell Biol Lipids; 2024 Jun; 1869(5):159497. PubMed ID: 38649009
[TBL] [Abstract][Full Text] [Related]
37. Ursodeoxycholic acid ameliorates hepatic lipid metabolism in LO2 cells by regulating the AKT/mTOR/SREBP-1 signaling pathway.
Hu J; Hong W; Yao KN; Zhu XH; Chen ZY; Ye L
World J Gastroenterol; 2019 Mar; 25(12):1492-1501. PubMed ID: 30948912
[TBL] [Abstract][Full Text] [Related]
38. [Intervention of Catalpol on High-fat Diet Induced Nonalcoholic Fatty Liver Disease in Mice].
Tian X; Xiong Q; Chen L; Wen JR; Ru Q
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Dec; 41(6):746-755. PubMed ID: 31907123
[No Abstract] [Full Text] [Related]
39. Silibinin Ameliorates Fructose-induced Lipid Accumulation and Activates Autophagy in HepG2 Cells.
Li Y; Ren L; Song G; Zhang P; Yang L; Chen X; Yu X; Chen S
Endocr Metab Immune Disord Drug Targets; 2019; 19(5):632-642. PubMed ID: 30734689
[TBL] [Abstract][Full Text] [Related]
40. SGL 121 Attenuates Nonalcoholic Fatty Liver Disease through Adjusting Lipid Metabolism Through AMPK Signaling Pathway.
Kim DE; Chang BY; Jeon BM; Baek JI; Kim SC; Kim SY
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32630596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
